The objective of this program is to accelerate brain–heart (B–H) research that has the potential to quickly deliver important and timely outcomes, and contribute to sustainable long-term health, societal and/or economic impacts that are equitable in their process and impact.

This funding opportunity will provide short-term catalytic support to enable researchers, in collaboration with patients and other knowledge users, to co-produce concrete deliverables within 1-year that advance evidence informed solutions to brain-heart health and health system challenges.

Overview

The maximum amount per project is $100,000 over one year. The total amount available is $800,000 to support up to eight projects. One grant will be reserved for a project led by an early-career researcher. Matched funding from partner organizations to expand the scope and contribution of the project is strongly encouraged.

Funding launch date: July 2, 2025

Application Deadline: August 8, 2025

Background Information

The Brain–Heart Interconnectome (BHI) is the first dedicated research program in Canada designed to unite diverse disciplines in a transdisciplinary effort to study, prevent and treat B–H disorders. Enabled by the Canada First Research Excellence Fund (CFREF) — a tri-agency initiative of the Social Sciences and Humanities Research Council (SSHRC), Natural Sciences and Engineering Research Council (NSERC) and Canadian Institutes of Health Research (CIHR) — the BHI supports the full spectrum of research, from fundamental to applied, including knowledge mobilization research. It promotes transformative collaborations across health care, the social sciences, the humanities, engineering and the natural sciences while fostering partnerships with community, provincial, national and international stakeholders across the academic, private and not-for-profit sectors. The BHI’s vision is for uOttawa and its partners to become global leaders in integrated, mission-driven B–H research that spans biomedical discovery, clinical interventions, service delivery models, community-based prevention, and research addressing health inequities.
The BHI fosters research excellence through its cross-cutting enablers, including Indigenous engagement; inclusion, diversity, equity, accessibility and social justice (IDEAS); co-production and knowledge mobilization; commercialization; patient engagement; and training and mentoring. BHI funding programs are integral to advancing the BHI’s IDEAS strategy, requiring integration of IDEAS principles in research design and practice, fostering diversity at all levels and nurturing a welcoming and bias- and stereotype-free culture.

Please see the BHI website for further information on the BHI’s goals and its foundations, themes and cross-cutting themes.

Objective of the Impact Grants Program

The objective of this program is to accelerate B–H research that has the potential to quickly deliver important and timely outcomes, and contribute to sustainable long-term health, societal and/or economic impacts that are equitable in their process and impact. This program will support projects that require funding to produce impactful deliverables that can be achieved within one year.

It will provide short-term catalytic support to enable researchers, in collaboration with knowledge users, to co-produce concrete deliverables that advance solutions to B–H health and health system challenges, and address the BHI’s intermediate and long-term outcomes, such as:

  • innovative social and clinical B–H interventions
  • collaboration to accelerate the mobilization of research findings
  • innovations in B–H health that are implemented in policy, practice or commercial products

Improvements to prevention, care and treatment of B–H conditions 
The Impact Grants program will support projects directly aligned with the BHI’s intermediate and long-term outcomes from the BHI’s Theory of Change in priority areas such as:

  • uncovering novel strategies or developing testing interventions for the prevention, diagnosis and/or treatment of interconnected brain and heart conditions
  • advancing B–H innovations along the commercialization pipeline
  • assessing the economic, health and/or societal impacts of interventions related to B–H health
  • assessing models and/or implementation of integrated care for B–H conditions